Unveiling 3 Analyst Insights On Arcturus Therapeutics
Unveiling 3 Analyst Insights On Arcturus Therapeutics
揭示了关于arcturus therapeutics的3个分析师见解
A comprehensive examination of how financial experts perceive Arcturus Therapeutics is...Providing a diverse range of perspectives from bullish to bearish, 3 analysts have published ratings on Arcturus Therapeutics (NASDAQ:ARCT) in the last three months.
在过去的三个月里，3位分析师对arcturus therapeutics（纳斯达克：ARCT）发布了从看好到看淡的多元化观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Arcturus Therapeutics, revealing an average target of $65.33, a high estimate of $70.00, and a low estimate of $63.00. This current average reflects an increase of 6.23% from the previous average price target of $61.50.
分析师为Arcturus Therapeutics设定了12个月的价格目标，展示了平均目标为65.33美元，高估为70.00美元，低估为63.00美元。当前的平均值反映了相较于之前的平均价格目标61.50美元的增长6.23%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级：全面解析
A comprehensive examination of how financial experts perceive Arcturus Therapeutics is...
最近分析师的行动得出了...
登录免费看全文
登录/注册
热门讨论
中概股持续上涨：哪些因素将主导后市？
🎙️讨论 1. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？ 2. 近期中概股上涨的主要驱动力是政策预期还是资金面改善？ 3. 若涨势延续，你会更关注技术面突破还是基本面支撑？
Moomoo News Global
03/04 23:26
中国两会：会议前后股票价格走势的主要要点